393 results on '"Applegate, Robert J."'
Search Results
2. Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study
3. Influence of Household Income on Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock
4. Echocardiography and EuroSCORE II for the stratification of low-gradient severe aortic stenosis and preserved left ventricular ejection fraction
5. Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection
6. Escalation strategies, management, and outcomes of acute myocardial infarction‐cardiogenic shock patients receiving percutaneous left ventricular support
7. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses
8. Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT IV Trial at 2 Years
9. List of Contributors
10. Cardiovascular Disease and Renal Transplantation
11. Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years
12. Angiographic Stenosis and Acute Coronary Syndromes: Progression of Stenoses to Myocardial Infarction
13. Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)
14. Three-Year Results of Safety and Efficacy of the Everolimus-Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)
15. 3-Year Comparison of Drug-Eluting Versus Bare-Metal Stents
16. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction
17. Trends in Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention Via the Femoral Artery, 1998 to 2007
18. ABO blood types: Influence on infarct size, procedural characteristics and prognosis
19. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting
20. Incidence of Coronary Stent Thrombosis Based on Academic Research Consortium Definitions
21. Conversations in Cardiology: Bridging antiplatelet therapy before surgery
22. Redo‐aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach
23. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction
24. Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention
25. Comparison of Drug-Eluting Versus Bare Metal Stents on Later Frequency of Acute Myocardial Infarction and Death
26. Safety of Abciximab Administration During PCI of Patients with Previous Stroke
27. Minimizing complications following stent implantation: outcomes and follow-up
28. Late outcomes after intervention of vein grafts in diabetics with abciximab use
29. The “Bladder Sign”—An Important Early Marker of Retroperitoneal Hemorrhage†
30. A novel technique for postclosure of large‐bore sheaths using two Perclose devices
31. Impact of the COVID ‐19 pandemic on interventional cardiology training in the United States
32. Charles Chambers MD MSCAI —A tribute
33. Impact of anatomical variations of the left ventricular outflow tract on stroke volume calculation by Doppler echocardiography in aortic stenosis
34. Rebuttal
35. The comparative safety of bare-metal and drug-eluting intracoronary stents
36. Gender Differences in the One Year Clinical Outcomes of Everolimus-eluting and Paclitaxel-eluting Stents: A Pooled Analysis from the SPIRIT III and IV Trials: D-042
37. Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: The SPIRIT III 4.0 mm registry
38. Treatment of ostial lesions using the Szabo technique: A case series
39. Late Outcomes of Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Grafts: Propensity Score Analysis
40. Drug-Eluting Stents for St Elevation Myocardial Infarction: Evidence for Benefit at Two Years: 2801-4
41. Propensity Score Analysis of Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention 1998-2003
42. Restenosis of a Sirolimus Drug-Eluting Stent: Aorto-Ostial Involvement of the Proximal Right Coronary Artery
43. Vascular Complications with Newer Generations of Angioseal Vascular Closure Devices
44. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel
45. Effects of constant cardiac autonomic nerve stimulation on heart rate variability
46. Redo‐aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
47. The effect of vagal stimulation on left ventricular systolic and diastolic performance
48. Effects of vasoactive intestinal peptide on myocardial performance
49. Effect of vasopressin on left ventricular performance
50. Angiographic Stenosis and Acute Coronary Syndromes: Progression of Stenoses to Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.